Skip to content
Research Article Open access CC BY 4.0

Prevalence and Molecular Characterization of P. aeruginosa Isolates in the West Bank-Palestine for ESBLs, MBLs and Integrons

Ghaleb Adwan, Amani Shtayah, Kamel Adwan, Suhaila Al-Sheboul, Sati Othman

Journal of Applied Life Sciences International · pp. 1–11 · Published 22 Sep 2016

10.9734/JALSI/2016/29259

Abstract

  Aims: This study aimed to determine the prevalence and molecular characterization of extended spectrum beta-lactamases (ESBLs), metallo-beta-lactamases (MBLs) and integrons among clinical isolates of Pseudomonas aeruginosa. Place and Duration of the Study: Department of Biology and Biotechnology, An-Najah National University-Nablus, Palestine, during October 2015-April 2016. Methodology: Fifty-one clinical isolates of Pseudomonas aeruginosa were obtained from different health centers in the West Bank-Palestine. Genes of ESBLs, MBLs and integrons were tested for in the isolates by conventional and/or molecular methods. Results: This study showed that 21.6% of P. aeruginosa isolates were ESBL producers using conventional methods. The prevalence of MBLs by conventional and molecular methods was 60.8% and 29.4% respectively. The most dominant MBL gene among MBL-producing P. aeruginosa isolates was blaVIM gene (60%), while the prevalence of blaIMP and blaSPM + blaVIM among the MBL-producing P. aeruginosa isolates was 33.3%, 6.7% respectively. Neither blaGIM nor blaSIM was detected. Result of the current research showed that 23.5% of P. aeruginosa isolates carried class I integrons. In these clinical isolates neither class 2 nor class 3 integrons were detected. Analysis of ERIC-PCR profiles of 15 P. aeruginosa isolates harboring MBL genes showed 4 identical clones circulating among the hospitals from which isolates were collected.   Conclusions: The present study showed high prevalence of MBLs and ESBLs among clinical isolates of P. aeruginosa in the West Bank-Palestine. Based on results of this study, effective measures should be taken to control the spread of ESBL- and MBL-producing pathogens including P. aeruginosa.  

Pseudomonas aeruginosa metallo-beta-lactamases extended spectrum beta-lactamases integrons Palestine

References (19)

  1. 1 Multiplex PCR for rapid detection of genes encoding acquired metallo- -lactamases [DOI]
  2. 2 Imipenem-EDTA Disk Method for Differentiation of Metallo-β-Lactamase-Producing Clinical Isolates of Pseudomonas spp. and Acinetobacter spp [DOI]
  3. 3 PCR Typing of Genetic Determinants for Metallo-β-Lactamases and Integrases Carried by Gram-Negative Bacteria Isolated in Japan, with Focus on the Class 3 Integron [DOI]
  4. 4 Epidemiology of Infections Due to Pseudomonas aeruginosa [DOI]
  5. 5 Hospital Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-1, a Novel Transferable Metallo- -Lactamase [DOI]
  6. 6 VIM- and IMP-Type Metallo-ß-lactamase–Producing Pseudomonas spp. and Acinetobacter spp. in Korean Hospitals [DOI]
  7. 7 Prevalence and Characterization of Class I Integrons among Pseudomonas aeruginosa and Acinetobacter baumannii Isolates from Patients in Nanjing, China [DOI]
  8. 8 Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme [DOI]
  9. 9 Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes amongPseudomonas aeruginosaStrains Isolated from Cancer Patients [DOI]
  10. 10 ESBL, MBL and Ampc Lactamases Producing Superbugs – Havoc in the Intensive Care Units of Punjab India [DOI]
  11. 11 Single-Nucleotide-Polymorphism Mapping of the Pseudomonas aeruginosa Type III Secretion Toxins for Development of a Diagnostic Multiplex PCR System [DOI]
  12. 12 Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis [DOI]
  13. 13 Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital [DOI]
  14. 14 Class 1 integrons in Pseudomonas aeruginosa and Acinetobacter baumannii isolated from clinical isolates.
  15. 15 ESBL and MBL in Cefepime Resistant Pseudomonas aeruginosa : An Update from a Rural Area in Northern India [DOI]
  16. 16 Antimicrobial resistance pattern and prevalence of metallo-β-lactamases in Pseudomonas aeruginosa from Saudi Arabia [DOI]
  17. 17 A clinicomicrobiological study on the importance of pseudomonas in nosocomially infected ICU patients, with special reference to metallo beta1-lactamase production.
  18. 18 Prevalence of Metallo- -Lactamases Producing Pseudomonas aeruginosa among the Clinical isolates: A study from tertiary care hospital
  19. 19 Genomic fingerprints analysis of coagulase-positive and negative Staphylococci isolated from patients with bacteremia by repetitive sequence based PCR method [DOI]

Cited by 11

Coexistence of Metallo Beta Lactamase Resistant Gene Variants Among Clinical Isolates in Tertiary Care Hospital

Santhiya K., Jayanthi S., Ananthasubramanian M. · Anti-Infective Agents · 2021

Resistance patterns and virulence factors of Pseudomonas aeruginosa in hospitalized patients: A Saudi Arabian study

Soha Abdallah Moursi, Mohd Saleem, Mohammed Salem Alharbi · Scientific Reports · 2025

Showing 6 of 11 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

76

Page views

0

PDF downloads

26

Outbound clicks

11

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.